Handelsbanken Fonder
LLY icon

Handelsbanken Fonder’s Eli Lilly LLY Stock Holding History

Handelsbanken Fonder’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$817M Sell
680,927
-27,617
-4% -$28.2M 2.33% 8
2026
Q1 		$652M Sell
708,544
-56,238
-7% -$57M 2.17% 8
2025
Q4 		$822M Sell
764,782
-87,727
-10% -$83.9M 2.48% 8
2025
Q3 		$650M Buy
852,509
+92,689
+12% +$69M 2.07% 8
2025
Q2 		$592M Buy
759,820
+25,944
+4% +$20.2M 2.1% 6
2025
Q1 		$606M Sell
733,876
-31,174
-4% -$25.9M 2.5% 4
2024
Q4 		$591M Sell
765,050
-1,975
-0.3% -$1.64M 2.25% 6
2024
Q3 		$680M Buy
767,025
+8,926
+1% +$8.02M 2.69% 4
2024
Q2 		$686M Sell
758,099
-37,511
-5% -$30M 2.98% 4
2024
Q1 		$619M Sell
795,610
-41,638
-5% -$29.6M 2.66% 4
2023
Q4 		$488M Sell
837,248
-12,962
-2% -$7.57M 2.37% 4
2023
Q3 		$457M Sell
850,210
-73,738
-8% -$38M 2.56% 4
2023
Q2 		$433M Buy
923,948
+17,514
+2% +$7.34M 2.32% 4
2023
Q1 		$311M Buy
906,434
+56,444
+7% +$19M 1.8% 5
2022
Q4 		$311M Buy
849,990
+23,585
+3% +$8.36M 1.95% 4
2022
Q3 		$267M Sell
826,405
-27,957
-3% -$8.86M 1.79% 4
2022
Q2 		$277M Sell
854,362
-57,965
-6% -$17.4M 1.8% 4
2022
Q1 		$261M Sell
912,327
-131,549
-13% -$33.9M 1.46% 8
2021
Q4 		$288M Sell
1,043,876
-4,344
-0.4% -$1.1M 1.42% 8
2021
Q3 		$242M Buy
1,048,220
+28,132
+3% +$6.94M 1.27% 10
2021
Q2 		$234M Buy
1,020,088
+24,300
+2% +$4.88M 1.22% 10
2021
Q1 		$186M Sell
995,788
-44,906
-4% -$8.78M 1.06% 14
2020
Q4 		$176M Buy
1,040,694
+49,503
+5% +$7.39M 1.07% 12
2020
Q3 		$147M Buy
991,191
+71,323
+8% +$11M 1.07% 15
2020
Q2 		$151M Buy
919,868
+111,396
+14% +$17.1M 1.27% 10
2020
Q1 		$112M Sell
808,472
-102,997
-11% -$14.2M 2.41% 5
2019
Q4 		$120M Buy
911,469
+24,983
+3% +$2.9M 2.07% 6
2019
Q3 		$99.1M Buy
886,486
+100,000
+13% +$11.1M 2% 9
2019
Q2 		$87.1M Buy
786,486
+197,076
+33% +$23.2M 1.61% 14
2019
Q1 		$76.5M Buy
589,410
+216,276
+58% +$26.3M 1.48% 19
2018
Q4 		$43.2M Buy
373,134
+12,994
+4% +$1.45M 0.87% 39
2018
Q3 		$38.6M Buy
360,140
+46,000
+15% +$4.6M 0.73% 47
2018
Q2 		$26.8M Hold
314,140
– – 0.53% 61
2018
Q1 		$24.3M Buy
314,140
+5,000
+2% +$403K 0.48% 65
2017
Q4 		$26.1M Buy
309,140
+8,200
+3% +$698K 0.57% 53
2017
Q3 		$25.7M Sell
300,940
-22,000
-7% -$1.8M 0.6% 53
2017
Q2 		$26.6M Buy
322,940
+55,000
+21% +$4.49M 0.68% 51
2017
Q1 		$22.5M Buy
267,940
+20,000
+8% +$1.6M 0.63% 58
2016
Q4 		$18.2M Buy
247,940
+6,000
+2% +$447K 0.56% 69
2016
Q3 		$19.4M Sell
241,940
-4,127
-2% -$330K 0.57% 70
2016
Q2 		$19.4M Hold
246,067
– – 0.79% 52
2016
Q1 		$17.7M Sell
246,067
-111,435
-31% -$8.43M 0.76% 51
2015
Q4 		$30.1M Buy
+357,502
New +$29.7M 0.58% 49

Other funds holding LLY

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Handelsbanken Fonder's LLY Position: Q2 2026 in Review

Handelsbanken Fonder reduced its Eli Lilly (LLY) stake by 3.9% in Q2 2026, selling an estimated $28.2M and leaving 680,927 shares worth $817M. The position accounts for 2.33% of the portfolio, ranked #8.

Handelsbanken Fonder first reported a position in LLY in Q4 2015 and has held it in 43 quarters since. The position peaked at $822M in Q4 2025. 911 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Handelsbanken Fonder held 680,927 shares of Eli Lilly worth $817M as of Q2 2026.
  • Handelsbanken Fonder sold 27,617 Eli Lilly shares in Q2 2026, an estimated $28.2M.
  • Eli Lilly made up 2.33% of Handelsbanken Fonder's portfolio in Q2 2026, its #8 holding.
  • Handelsbanken Fonder first reported a position in Eli Lilly in Q4 2015 and has held it in 43 quarters since.
  • Handelsbanken Fonder's Eli Lilly position peaked at $822M in Q4 2025.
  • 911 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.